In this March 16, 2020 file photo, a subject receives a shot in the first-stage safety study clinical trial of a vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle.

Moderna seeks Canada’s approval for COVID-19 vaccine use in kids 12 and up

‘We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents,’ the company said.

Global News
0 Comments